Author:
Park Kyung En,Zhai Qihui “Jim”,Deng Fang-Ming
Publisher
Springer International Publishing
Reference73 articles.
1. Moch H, Humphrey PA, Ulbright TM, Reuter V. WHO classification of tumors of the urinary system and male genital organs. Lyon: International Agency for Research on Cancer; 2016.
2. Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA. Clinical outcomes of patients with histologic variants of urothelial Cancer treated with Trimodality bladder-sparing therapy. Eur Urol. 2017 Jul;72(1):54–60.
3. Zargar-Shoshtari K, Sverrisson EF, Sharma P, et al. Clinical outcomes after neoadjuvant chemotherapy and radical cystectomy in the presence of urothelial carcinoma of the bladder with squamous or glandular differentiation. Clin Genitourin Cancer. 2016;14:82–8.
4. Gofrit ON, Yutkin V, Shapiro A, et al. The response of variant histology bladder cancer to intravesical immunotherapy compared to conventional cancer. Front Oncol. 2016;15:43.
5. Wasco MJ, Daignault S, Zhang Y, Kunju LP, Kinnaman M, Braun T, Lee CT, Shah RB. Urothelial carcinoma with divergent histologic differentiation (mixed histologic features) predicts the presence of locally advanced bladder cancer when detected at transurethral resection. Urology. 2007 Jul;70(1):69–74.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献